Jupiter Neurosciences (JUNS) vs Onconetix (ONCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Jupiter Neurosciences is the larger company by market cap ($3.7 million vs $3.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | JUNS | ONCO |
|---|---|---|
| Share price | $2.77 | $0.6543 |
| Market cap | $3.65M | $3.43M |
| 1-day change | -2.46% | +9.56% |
| P/E ratio (TTM) | — | 0.00 |
| Forward P/E | 46.17 | — |
| EPS (TTM) | $-18.94 | $310.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $135.75 | $209.50 |
| 52-week low | $2.25 | $0.58 |
| Distance from 52-week high | -97.96% | -99.69% |
| Average volume | 982.67K | 2.23M |
| Shares outstanding | 1.32M | 5.24M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
JUNS vs ONCO FAQ
Which is bigger, Jupiter Neurosciences or Onconetix?
Jupiter Neurosciences (JUNS) is larger, with a market capitalization of $3.65M compared with $3.43M for Onconetix (ONCO).
Are Jupiter Neurosciences and Onconetix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.